AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effectiveness of Tele-Rehabilitation in Managing Rhomboid Trigger Points in Patients With Myofascial Pain Syndrome

RecruitingNAAges 18 Years - 35 YearsAllRiphah International University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial aims to assess the effectiveness of tele-rehabilitation, including self-myofascial release and exercise therapy, in reducing pain, improving functional range of motion, and decreasing neck disability in patients with rhomboid trigger points associated with myofascial pain syndrome.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Participants falling in this category would be recruited into the study. * Age 18-35 years * Both Genders: Male and Female * Paitents experiencing Neck and upper back pain due to active trigger points.(16) According to Travell and Simons (1999)criteria, active myofascial trigger points (MTrPs) are identified. * NPRS โ‰ฅ4 * Presence of maximum one or more than one MTrPs in the Romboids muscle. * Prolong sitting at least 6 hours per day. * Access to a device with internet connection ( for tele rehabilitation group). Exclusion Criteria: * Participants falling in this category would be excluded from the study. * Participants fall in this category would be excluded of the study. * Patients currently taking analgesics (painkillers) or muscle relaxants. * Any inflammatory pathology, neurological impairment, and cervical tumor. * Other deformities such as scoliosis or torticollis. * Spinal Injuries and any other co morbidity. * Any surgery, trauma, fracture and fall. * Pregnancy. * Patient unwilling to comply follow up schedule. * Patient involvement in another interventional study.
๐Ÿ’Š

What it tests

  • Tele-rehabilitation (ET + Self-Myofascial Release)
  • Conventional Myofascial Release Treatment
๐Ÿ“

Where

1 site
JPMC
Karachi, Pakistan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy